Subcutaneous Interferon Beta Therapy in Multiple Sclerosis Patients – Characterization of Injection Site Reactions and Flu-Like Symptoms in a Daily Practice Setting – Results from the Non-Interventional Study PERFECT

Subcutaneous Interferon Beta Therapy in Multiple Sclerosis Patients – Characterization of Injection Site Reactions and Flu-Like Symptoms in a Daily Practice Setting – Results from the Non-Interventional Study PERFECT

Borries Kukowski,1 Karin Rehberg-Weber,2 Kirsi Taipale,2 Andreas Kowalik,3 Patrick Oschmann4 1Neurologische Gemeinschaftspraxis, Göttingen, Germany; 2Biogen GmbH, Munich, Germany; 3Praxis Dr. Kowalik, Stuttgart, Germany; 4Klinik für Neurologie, Klinikum Bayreuth GmbH, Bayreuth, Ger...

Full description

Bibliographic Details
Main Authors: Kukowski B, Rehberg-Weber K, Taipale K, Kowalik A, Oschmann P
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Patient Preference and Adherence
Subjects:
peginterferon beta-1a
post-authorization safety study
real-world
erythema
disease-modifying therapy
Online Access:https://www.dovepress.com/subcutaneous-interferon-beta-therapy-in-multiple-sclerosis-patients--c-peer-reviewed-fulltext-article-PPA

Internet

https://www.dovepress.com/subcutaneous-interferon-beta-therapy-in-multiple-sclerosis-patients--c-peer-reviewed-fulltext-article-PPA

Similar Items